Hemispherx Biopharma Gains Regulatory Approval in Latin America
January 26, 2012 08:30 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, Jan. 26, 2012 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") today announced that ANMAT (Administracion Nacional de Medicamentos,...
Hemispherx Biopharma, Inc. to Host Conference Call on Chronic Fatigue Syndrome Progress Thursday, October 27, 2011
October 24, 2011 10:22 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, Oct. 24, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex: HEB) (the "Company"), has scheduled a conference call and audio webcast on Thursday, October 27, 2011 at 2:00...
Hemispherx Biopharma's 2011 Stockholder Annual Meeting Set
September 19, 2011 08:00 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, Sept. 19, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company") will hold its Annual Meeting of stockholders on Thursday, October 13, 2011, at 10 a.m. EDT,...
Breast Cancer Study With Hemispherx Biopharma's Ampligen(R) Commences
August 22, 2011 10:00 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, Aug. 22, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE AMEX:HEB) announced that investigators from the Tumor Vaccine Group (TVG) at the University of Washington in Seattle, WA,...
FDA Authorizes New Hemispherx Biopharma Clinical Trial of Intranasal Ampligen(R) With Seasonal Influenza Vaccine
July 20, 2011 08:00 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, July 20, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") today announced it has received U.S. Food Drug Administration (FDA)...
Hemispherx Biopharma to Present at Noble Financial Capital Markets' Annual Equity Conference
May 16, 2011 12:21 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, May 16, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") today announced that its Senior Advisor to the CEO, Wayne Pambianchi, will...
Hemispherx Biopharma's Ampligen(R) Cited at Barcelona Vaccine & Active Immunotherapeutics Forum 2011
May 12, 2011 13:00 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, May 12, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") today announced that Ampligen® will be featured in a discussion of...
Chronix Biomedical and Hemispherx Biopharma Jointly File Patent Application for a Blood Test for Chronic Fatigue Syndrome (CFS)
March 03, 2011 10:00 ET
|
Hemispherx Biopharma, Inc.
Chronix Technology Focuses on Changes to CFS Patients' DNA
Hemispherx and Chronix Plan Studies to Validate Technology as a Potential Diagnostic Test for CFS
SAN JOSE, Calif., March 3, 2011...